Share
𝕏 Facebook LinkedIn

Investigating the expression changes of several key genes in prostate cancer cells under exposure to the ELF pulsed electromagnetic fields.

PAPER pubmed Scientific reports 2025 In vitro study Effect: benefit Evidence: Low

Abstract

One of the less invasive methods in cancer treatment is the use of Extremely Low-Frequency Pulsed-Electromagnetic Fields (ELF P-EMF). In this study, after culturing and proliferating DU-145 prostate cancer cells, they were exposed to ELF P-EMF with different intensities and times. Then, the cells' viability was examined by applying the MTT test, and their level of apoptosis/ necrosis was analyzed using a flow cytometry test. Then, for the studied groups, RNA extraction steps were performed, and cDNA was subsequently synthesized. Finally, using Real-time PCR, the expression levels of key genes such as PTEN, BAX, BCL-2, and MIR-21 in the targeted cancer cells were examined, and statistically, the significance of their expression differences with the control group was measured using SPSS software. The results indicated that by increasing the ELF P-EMF intensity from 22.6 to 35 mT and the duration of exposure, the mortality rate of cancer cells increased significantly. In addition, exposing cells of this line to ELF P-EMF could induce apoptosis in these cells. Also, applying fields with intensities of 22.6 and 35 mT led to a significant increase in the expression of the tumor suppressor gene PTEN and an increase in the expression of the apoptosis-inducing gene BAX. In addition, applying the field significantly reduced the expression of the oncogene MIR-21 and, to some extent, reduced the expression of the BCL-2 gene, which blocks apoptosis.

AI evidence extraction

At a glance
Study type
In vitro study
Effect direction
benefit
Population
DU-145 prostate cancer cells
Sample size
Exposure
ELF pulsed electromagnetic fields (ELF P-EMF) · different intensities and times (duration not specified)
Evidence strength
Low
Confidence: 78% · Peer-reviewed: yes

Main findings

Increasing ELF P-EMF intensity from 22.6 to 35 mT and increasing exposure duration significantly increased cancer cell mortality. ELF P-EMF exposure induced apoptosis and was associated with increased PTEN and BAX expression, reduced MIR-21 expression, and some reduction in BCL-2 expression versus control.

Outcomes measured

  • Cell viability (MTT)
  • Apoptosis/necrosis (flow cytometry)
  • Gene expression (RT-PCR): PTEN
  • Gene expression (RT-PCR): BAX
  • Gene expression (RT-PCR): BCL-2
  • Gene expression (RT-PCR): MIR-21

Limitations

  • In vitro study in a single prostate cancer cell line (DU-145)
  • Exposure frequency and waveform details not reported in abstract
  • Exposure durations and number of experimental replicates/sample size not reported in abstract

Suggested hubs

  • elf-emf (0.9)
    Study uses extremely low-frequency pulsed electromagnetic fields (mT range) in a cell model.
  • cancer-in-vitro (0.75)
    In vitro prostate cancer cell study assessing viability, apoptosis, and gene expression changes.
View raw extracted JSON
{
    "study_type": "in_vitro",
    "exposure": {
        "band": "ELF",
        "source": "pulsed electromagnetic fields (ELF P-EMF)",
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": "different intensities and times (duration not specified)"
    },
    "population": "DU-145 prostate cancer cells",
    "sample_size": null,
    "outcomes": [
        "Cell viability (MTT)",
        "Apoptosis/necrosis (flow cytometry)",
        "Gene expression (RT-PCR): PTEN",
        "Gene expression (RT-PCR): BAX",
        "Gene expression (RT-PCR): BCL-2",
        "Gene expression (RT-PCR): MIR-21"
    ],
    "main_findings": "Increasing ELF P-EMF intensity from 22.6 to 35 mT and increasing exposure duration significantly increased cancer cell mortality. ELF P-EMF exposure induced apoptosis and was associated with increased PTEN and BAX expression, reduced MIR-21 expression, and some reduction in BCL-2 expression versus control.",
    "effect_direction": "benefit",
    "limitations": [
        "In vitro study in a single prostate cancer cell line (DU-145)",
        "Exposure frequency and waveform details not reported in abstract",
        "Exposure durations and number of experimental replicates/sample size not reported in abstract"
    ],
    "evidence_strength": "low",
    "confidence": 0.7800000000000000266453525910037569701671600341796875,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "ELF",
        "pulsed electromagnetic fields",
        "ELF P-EMF",
        "prostate cancer",
        "DU-145",
        "MTT",
        "flow cytometry",
        "apoptosis",
        "PTEN",
        "BAX",
        "BCL-2",
        "MIR-21",
        "gene expression",
        "real-time PCR"
    ],
    "suggested_hubs": [
        {
            "slug": "elf-emf",
            "weight": 0.90000000000000002220446049250313080847263336181640625,
            "reason": "Study uses extremely low-frequency pulsed electromagnetic fields (mT range) in a cell model."
        },
        {
            "slug": "cancer-in-vitro",
            "weight": 0.75,
            "reason": "In vitro prostate cancer cell study assessing viability, apoptosis, and gene expression changes."
        }
    ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.